{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Samples&page=3", "query": { "intervention": "Samples", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 3019, "total_pages": 302, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Samples&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Samples&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T07:29:30.499Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05092958", "title": "Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced Bladder Urothelial Carcinoma", "Advanced Renal Pelvis Urothelial Carcinoma", "Advanced Ureter Urothelial Carcinoma", "Advanced Urethral Urothelial Carcinoma", "Metastatic Bladder Urothelial Carcinoma", "Metastatic Renal Pelvis Urothelial Carcinoma", "Metastatic Ureter Urothelial Carcinoma", "Metastatic Urethral Urothelial Carcinoma", "Stage III Bladder Cancer AJCC v8", "Stage III Renal Pelvis and Ureter Cancer AJCC v8", "Stage III Renal Pelvis Cancer AJCC v8", "Stage III Ureter Cancer AJCC v8", "Stage III Urethral Cancer AJCC v8", "Stage IV Bladder Cancer AJCC v8", "Stage IV Renal Pelvis and Ureter Cancer AJCC v8", "Stage IV Renal Pelvis Cancer AJCC v8", "Stage IV Ureter Cancer AJCC v8", "Stage IV Urethral Cancer AJCC v8" ], "interventions": [ { "name": "Avelumab", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Cabozantinib S-malate", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 654, "start_date": "2022-06-03", "completion_date": "2029-07-15", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 271, "location_summary": "Phoenix, Arizona • Auburn, California • Berkeley, California + 214 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Auburn", "state": "California" }, { "city": "Berkeley", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Modesto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05092958" }, { "nct_id": "NCT03883126", "title": "Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alcohol Use Disorder" ], "interventions": [ { "name": "Contingency management", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Mikhail N Koffarnus", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 211, "start_date": "2020-06-16", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 3, "location_summary": "Lexington, Kentucky • Roanoke, Virginia", "locations": [ { "city": "Lexington", "state": "Kentucky" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Roanoke", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03883126" }, { "nct_id": "NCT00488878", "title": "Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Low Grade Ovarian Serous Adenocarcinoma", "Malignant Ovarian Neoplasm", "Ovarian Carcinoma", "Primary Peritoneal Carcinoma", "Primary Peritoneal Low Grade Serous Adenocarcinoma", "Psammocarcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Electronic Health Record Review", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 2000, "start_date": "2006-05-19", "completion_date": "2035-05-01", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00488878" }, { "nct_id": "NCT06929455", "title": "Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthy Adults" ], "interventions": [ { "name": "Flavor additives", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Monell Chemical Senses Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 100, "start_date": "2025-03-18", "completion_date": "2026-11-01", "has_results": false, "last_update_posted_date": "2025-04-16", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06929455" }, { "nct_id": "NCT04022889", "title": "In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "INTERCEPT Treated Platelets", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cerus Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2019-11-05", "completion_date": "2021-04-17", "has_results": true, "last_update_posted_date": "2022-10-27", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 2, "location_summary": "Cincinnati, Ohio • Seattle, Washington", "locations": [ { "city": "Cincinnati", "state": "Ohio" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04022889" }, { "nct_id": "NCT02784821", "title": "Antibiotic \"Dysbiosis\" in Preterm Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Enterocolitis, Necrotizing", "Bacteremia", "Bronchopulmonary Dysplasia", "Intraventricular Hemorrhage", "Periventricular Leukomalacia", "Chronic Lung Disease", "Ileal Perforation" ], "interventions": [ { "name": "Antibiotic", "type": "DRUG" }, { "name": "Gastric fluid", "type": "OTHER" }, { "name": "Breast milk", "type": "OTHER" }, { "name": "Stool samples", "type": "OTHER" }, { "name": "Antibiotics", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "23 Weeks", "maximum_age": "33 Weeks", "sex": "ALL", "summary": "23 Weeks to 33 Weeks" }, "enrollment_count": 98, "start_date": "2017-01-16", "completion_date": "2019-09-11", "has_results": true, "last_update_posted_date": "2024-06-05", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02784821" }, { "nct_id": "NCT01750203", "title": "Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Wounds With Different Etiologies" ], "interventions": [ { "name": "Swabs", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Systagenix Wound Management", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 135, "start_date": "2012-12", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2012-12-20", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 1, "location_summary": "Tulsa, Oklahoma", "locations": [ { "city": "Tulsa", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT01750203" }, { "nct_id": "NCT04494945", "title": "Identifying and Caring for Individuals With Inherited Cancer Syndrome", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome", "Breast Ductal Carcinoma In Situ", "Hematopoietic and Lymphoid System Neoplasm", "Hereditary Neoplastic Syndrome", "Lynch Syndrome", "Malignant Solid Neoplasm" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Genetic Counseling", "type": "OTHER" }, { "name": "Genetic Testing", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27500, "start_date": "2020-03-09", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 2, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04494945" }, { "nct_id": "NCT04831840", "title": "Recurrent Urinary Tract Infections and the Microbiome", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Recurrent Urinary Tract Infection" ], "interventions": [], "intervention_types": [], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "FEMALE", "summary": "18 Years to 90 Years · Female only" }, "enrollment_count": 32, "start_date": "2021-05-26", "completion_date": "2023-11-20", "has_results": false, "last_update_posted_date": "2024-05-21", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 2, "location_summary": "Fort Lauderdale, Florida • Miami, Florida", "locations": [ { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04831840" }, { "nct_id": "NCT00323323", "title": "CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-Hodgkin's Lymphoma" ], "interventions": [ { "name": "CHOP", "type": "DRUG" }, { "name": "Alemtuzumab", "type": "DRUG" }, { "name": "Plasma Samples", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2004-03", "completion_date": "2016-10", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-10-20T07:29:30.499Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00323323" } ] }